Eric A. Dietrich, PharmD, BCPS

While its pharmacokinetics suggest that apixaban is adequate for use in patients on hemodialysis, is there clear evidence showing that the agent is both safe and effective in this role?

As with the decision to initiate or continue warfarin therapy, decisions surrounding bridge therapy are patient-specific and should be evaluated on a case-by-case basis.

A 63-year-old white woman presented for continued workup for shortness of breath and an ongoing cough.

We have recently been following KD, a 58-year-old male who was diagnosed with a first unprovoked deep vein thrombosis (DVT). After completing 3 months of treatment with warfarin, KD elected to continue...

In last issue’s column, we discussed the case of JG, a patient with newly diagnosed hypertension (HTN).

Unprovoked DVT is a term used to describe the occurrence of DVT in the absence of currently recognized triggers, such as surgery, long-haul travel, immobilization, or trauma.